🚀 Click here to get access to our Free Course on Momentum Investing Strategy 🚀

*

Market Insights

Stock screens updated daily — built in Wright’s visual language.

Stock screens updated daily — built in Wright’s visual language.

Top Growth Stocks

Growth stocks are equities of companies prioritizing rapid revenue and earnings expansion over immediate profits or dividends, typically reinvesting earnings into future development. Key characteristics include high growth potential, significant market disruption, volatility, and elevated valuations (often reflected in high price-to-earnings ratios). Their primary advantage is substantial upside potential during economic expansion and innovation-driven markets, making them attractive for long-term capital appreciation.

Updated:
Ticker Security Name ⇅ PrevClose Beta MarketCap PE Ratio ⇅ Dividend Yield PBV Ratio ⇅ Category
ANANTRAJ Anant Raj Ltd. 489.15 1.016 16771.467 41.322 0.002 4.211 Mid-Cap
CGCL Capri Global Capital Ltd. 161.24 0.306 13125.966 33.256 0.001 3.143 Mid-Cap
ASTRAZEN Astrazeneca Pharma India Ltd. 8704.5 0.434 19188.844 191.205 0.003 27.144 Mid-Cap
CHOICEIN Choice International Ltd. 702.55 0.376 9596.442 62.893 0.0 10.351 Mid-Cap
KRN KRN Heat Exchanger And Refrigeration Ltd. 926.45 0.0 5774.35 141.443 0.0 11.091 Mid-Cap
CCL CCL Products (India) Ltd. 1015.8 0.609 7616.44 26.774 0.008 4.033 Mid-Cap
ASTRAMICRO Astra Microwave Products Ltd. 1038.05 1.073 5916.031 42.517 0.003 5.797 Mid-Cap
AURIONPRO Aurionpro Solutions Ltd. 858.7 0.775 7208.391 38.373 0.001 4.928 Mid-Cap
CENTURYPLY Century Plyboards (India) Ltd. 705.05 0.969 15684.282 71.174 0.001 6.679 Mid-Cap
CAPLIPOINT Caplin Point Laboratories Ltd. 1664.8 0.752 14000.958 26.302 0.003 5.291 Mid-Cap
No data found for this filter.

Select a filter to view information.

Details

About Anant Raj Ltd. and Its Industry:

Anant Raj Ltd. is a specialized manufacturer of industrial components and systems, primarily serving sectors like infrastructure, energy, and automotive. The company focuses on producing high-precision, engineered parts and integrated solutions, often utilizing advanced manufacturing techniques to meet demanding quality standards. Its role within the industry centers on providing critical, value-added components that support the performance and reliability of larger industrial systems, positioning it as a key supplier to both domestic and international clients in the manufacturing value chain. The company faces significant challenges including fluctuating raw material costs, intense competition from established global players and lower-cost regional manufacturers, and the pressure to continuously innovate to meet evolving client specifications.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹489.15
    • Market Cap: ₹16771.467
    • Category: Mid-Cap
    • Beta: 1.016
  • P/E Ratio: 41.322
  • Dividend Yield: 0.002%
  • Price-to-Book Value (PBV): 4.211

About Capri Global Capital Ltd. and Its Industry:

Capri Global Capital Ltd. is an Indian investment banking firm specializing in providing strategic advisory services to corporations, private equity firms, and institutions. Its core operations focus on mergers and acquisitions (M&A), capital raising, restructuring, and financial advisory across various sectors within the Indian market. The company plays a key role in facilitating complex transactions and shaping corporate strategy for its clients, positioning itself as a mid-sized player navigating the dynamic Indian financial services landscape. The company faces significant challenges including intense competition from larger domestic and international banking firms, navigating evolving regulatory requirements, and the inherent cyclicality of the advisory business tied to broader economic conditions.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹161.24
    • Market Cap: ₹13125.966
    • Category: Mid-Cap
    • Beta: 0.306
  • P/E Ratio: 33.256
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 3.143

About Astrazeneca Pharma India Ltd. and Its Industry:

AstraZeneca Pharma India Ltd. is a leading subsidiary of the global pharmaceutical giant AstraZeneca PLC, operating within India's dynamic healthcare sector. It focuses on developing, manufacturing, and distributing innovative medicines primarily in key therapeutic areas including oncology, respiratory, and cardiovascular diseases. As a significant player in the Indian pharmaceutical market, the company contributes substantially to healthcare access through its extensive portfolio of branded and generic products, while also conducting research and clinical trials locally to address the specific needs of Indian patients. The company faces challenges such as intense competition from domestic and international generic manufacturers, evolving regulatory requirements, and the constant pressure to manage pricing pressures within the Indian healthcare system.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹8704.5
    • Market Cap: ₹19188.844
    • Category: Mid-Cap
    • Beta: 0.434
  • P/E Ratio: 191.205
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 27.144

About Choice International Ltd. and Its Industry:

Choice International Ltd. operates as a global logistics and supply chain solutions provider, facilitating the movement of goods across international borders for diverse clients. The company specializes in managing complex shipping, customs clearance, warehousing, and distribution networks, connecting manufacturers and retailers with markets worldwide. It plays a critical role within the global trade ecosystem by streamlining international commerce, ensuring efficient and compliant flow of products, and offering integrated services that reduce friction in cross-border transactions for its clients. The company navigates significant challenges including evolving and fragmented international trade regulations, persistent geopolitical tensions disrupting routes and costs, and intense competition from both established players and emerging digital logistics platforms.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹702.55
    • Market Cap: ₹9596.442
    • Category: Mid-Cap
    • Beta: 0.376
  • P/E Ratio: 62.893
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 10.351

About KRN Heat Exchanger And Refrigeration Ltd. and Its Industry:

KRN Heat Exchanger And Refrigeration Ltd. operates as a specialized manufacturer and provider of heat exchangers and refrigeration systems, serving critical industrial sectors including oil and gas, power generation, petrochemicals, and manufacturing. The company focuses on designing, engineering, and supplying high-performance thermal management solutions essential for processes requiring efficient heat transfer and cooling, positioning itself as a key supplier within the industrial equipment and services landscape. The company faces ongoing challenges related to global supply chain disruptions and the volatility of raw material costs, which can impact production timelines and margins.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹926.45
    • Market Cap: ₹5774.35
    • Category: Mid-Cap
    • Beta: 0.0
  • P/E Ratio: 141.443
  • Dividend Yield: 0.0%
  • Price-to-Book Value (PBV): 11.091

About CCL Products (India) Ltd. and Its Industry:

CCL Products (India) Ltd. operates as a leading manufacturer of corrugated and solid board packaging solutions in India. The company primarily serves the food and beverage, electronics, and consumer goods sectors, producing a wide range of cartons, containers, and packaging components designed for protection, branding, and efficient logistics. Its core role within the industry is to provide essential packaging infrastructure that enables its clients to safely transport, store, and display their products, contributing significantly to the supply chain efficiency and marketability of numerous consumer brands across the country. The company faces significant challenges including intense competition from both large established players and numerous smaller regional manufacturers, alongside growing pressure to adopt sustainable packaging materials and processes to meet evolving environmental regulations and consumer expectations.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1015.8
    • Market Cap: ₹7616.44
    • Category: Mid-Cap
    • Beta: 0.609
  • P/E Ratio: 26.774
  • Dividend Yield: 0.008%
  • Price-to-Book Value (PBV): 4.033

About Astra Microwave Products Ltd. and Its Industry:

Astra Microwave Products Ltd. is a specialized manufacturer of advanced microwave and radio frequency components, primarily serving the aerospace, defense, and telecommunications sectors. The company designs and produces critical high-performance devices such as amplifiers, filters, and signal generators used in radar systems, satellite communications, and military electronics. Astra positions itself as a reliable supplier of precision-engineered solutions, focusing on niche applications where stringent performance and reliability standards are paramount within its industry. The company faces challenges related to intense competition from both established global players and agile regional innovators, alongside the persistent pressure of managing complex, long supply chains for specialized materials.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1038.05
    • Market Cap: ₹5916.031
    • Category: Mid-Cap
    • Beta: 1.073
  • P/E Ratio: 42.517
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.797

About Aurionpro Solutions Ltd. and Its Industry:

Aurionpro Solutions Ltd. is a prominent Indian IT services and consulting firm specializing in SAP solutions and enterprise application services. The company provides end-to-end services including SAP implementation, migration, support, and advisory across various industries like manufacturing, retail, and healthcare. Aurionpro plays a significant role as a specialized partner within the broader IT services industry, focusing on delivering tailored digital transformation solutions that integrate core SAP platforms with modern technologies to enhance client business processes. The company faces challenges such as intense competition from larger global IT players and the ongoing pressure to retain key talent in a volatile market.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹858.7
    • Market Cap: ₹7208.391
    • Category: Mid-Cap
    • Beta: 0.775
  • P/E Ratio: 38.373
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 4.928

About Century Plyboards (India) Ltd. and Its Industry:

Century Plyboards (India) Ltd. is a prominent Indian manufacturer of wood-based panels, primarily plywood, particle board, and oriented strand board (OSB). As a key player in the country's construction and furniture industries, the company leverages a large-scale production footprint and an integrated supply chain, from timber sourcing to finished goods, to serve diverse domestic and international markets. It holds a significant market share and is recognized for its brand strength within the Indian wood products sector. The company faces ongoing challenges including intense competition, fluctuating costs of raw materials like timber and resin, and increasing regulatory pressures concerning sustainable sourcing and environmental compliance.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹705.05
    • Market Cap: ₹15684.282
    • Category: Mid-Cap
    • Beta: 0.969
  • P/E Ratio: 71.174
  • Dividend Yield: 0.001%
  • Price-to-Book Value (PBV): 6.679

About Caplin Point Laboratories Ltd. and Its Industry:

Caplin Point Laboratories Ltd. is a pharmaceutical company focused on the manufacturing and marketing of generic pharmaceutical products and active pharmaceutical ingredients (APIs). Its operations encompass the development, production, and distribution of a wide range of high-quality, cost-effective generic medicines primarily for global markets, particularly in the United States, Europe, and Asia. As a key player in the generics sector, the company contributes significantly to improving patient access to essential medications by offering affordable alternatives to branded drugs, thereby playing a vital role in the healthcare industry's ecosystem of value-driven medication delivery.

Key Metrics:

  • Stock Price & Market Capitalization:
    • Prev Close: ₹1664.8
    • Market Cap: ₹14000.958
    • Category: Mid-Cap
    • Beta: 0.752
  • P/E Ratio: 26.302
  • Dividend Yield: 0.003%
  • Price-to-Book Value (PBV): 5.291